Thus, we speculated that miR‐30b‐5p could inhibit EZH2 to regulate the activation of PI3K/AKT signalling pathway, thus participating in the occurrence and development of NSCLC. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.